Varenicline
Drug0.5mg capsules x 2, 2x a day for 12 weeks
Other names: Chantix
NCT Number: NCT01146613
The primary objective of this study is to assess the efficacy of varenicline in reducing the proportion of heavy drinking days during the last 8 weeks of treatment in subjects with alcohol dependence confirmed by Diagnostic and Statistical Manual of Mental Disorders-IV-Text Revision (DSM-IV-TR) criteria and who frequently consume 10 or more drinks per drinking day for men and 8 or more drinks for women (designated as "very heavy" drinkers).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
0.5mg capsules x 2, 2x a day for 12 weeks
Other names: Chantix
identical matched placebo x 2, 2xday, 13 weeks
Time frame: Weeks 2-13*
Protocol: The primary outcome measure examines the hypothesis that varenicline will decrease the weekly proportion of heavy drinking days during Study Weeks 2 through 13 as compared to placebo.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Nih
A Phase 2, Double Blind, Placebo Controlled Trial to Assess the Efficacy of Varenicline Tartrate for Alcohol Dependence in Very Heavy Drinkers
Acronym: NCIG 003
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03152760
Alcohol-Related Disorders, Alcoholism
Bethesda, Maryland, United States
View Trial DetailsNCT02181569
Alcohol-Related Disorders, Alcoholism
Bethesda, Maryland, United States
View Trial DetailsNCT03120468
Alcohol-Related Disorders, Alcoholism
Charlottesville, Virginia, United States
View Trial DetailsNCT03969251
Alcohol-Related Disorders, Alcoholism
Charlottesville, Virginia, United States
View Trial Details